非手术食管癌CT临床分期的试用及探讨  

Trial and Discussion of CT Staging of Non-surgical Esophageal Cancer

作　　者：孙荣刚 刘锐[2] 于明艳 林贵州 高洋 鄂有国 曹德华[1] SUN Ronggang;LIU Rui;YU Mingyan(Yangzhong People’s Hospital,Yangzhong 212200,China)

机构地区：[1]江苏省扬中市人民医院,江苏扬中212200 [2]西安交通大学第一附属医院

出　　处：《中国医学创新》2019年第16期139-142,共4页Medical Innovation of China

摘　　要：目的:探讨非手术食管癌CT临床分期方法试用情况。方法:收集2014年1月-2017年8月本院放疗科收治的非手术食管癌放疗患者,基于胸部CT设计新的临床分期,通过生存分析验证其适用性。结果:112例老年食管癌患者1、2、3、4年总生存率分别是54%、34%、30%、28%。按照新的方法检验生存率,T分期:T0、T1两组生存曲线分开较好,但差异无统计学意义(Х^2=2.614,P=0.106)。N分期:N0、N1、N2三组生存率比较,差异均有统计学意义(Х^2=11.639,P=0.003)。新的临床分期:Ⅰ期、Ⅱ期、Ⅲ期三组生存曲线分离明显,差异均有统计学意义(Х^2=16.198,P=0.000)。结论:基于胸部CT新的临床分期能较好地判断预后,值得进一步研究。Objective:To explore the clinical staging of non-surgical esophageal cancer by CT.Method:Non-surgical patients with esophageal cancer who were admitted to the Radiotherapy Department of our hospital from January 2014 to August 2017 were collected.Designed a new clinical stage based on chest CT and validated its applicability through survival analysis.Result:The1,2,3,4 year over all survival rate of112 elderly patients with esophageal cancer was 54%,34%,30%and 28%.Survival rate was tested according to new method,T stage:the survival curves of T0 and T1 group were well separated,but the differences wasno statistically significant(Х^2=2.614,P=0.106).N stage:the survival rate of N0,N1,N2 group were compared,the differences were statistically significant(Х^2=11.639,P=0.003).The new clinical stage:the survival curves of the stageⅠ,stageⅡand stageⅢgroup were significantly separated,the differences were statistically significant(Х^2=16.198,P=0.000).Conclusion:The new clinical staging based on chest CT can better judge the prognosis and deserves further study.

关 键 词：老年患者 食管癌 临床分期 预后 

分 类 号：R735.1[医药卫生—肿瘤]